Beyond tumors: uninvolved breast tissue of breast cancer patients with adverse prognoses is enriched for pathogenic PIK3CA and TP53 post-zygotic variants

Maria Andreou(Gdańsk Medical University), Arkadiusz Piotrowski(Gdańsk Medical University), Urszula Ławrynowicz(Gdańsk Medical University), Anna Kostecka(Gdańsk Medical University), Marcin Jąkalski(Gdańsk Medical University), Katarzyna Duzowska(Gdańsk Medical University), Michał Jankowski(Nicolaus Copernicus University), Monika Horbacz(Gdańsk Medical University), Tomasz Nowikiewicz, Jakub Mieczkowski(Gdańsk Medical University), Bożena Bruhn‐Olszewska(Uppsala University), Magdalena Koczkowska(Gdańsk Medical University), Hanna Davies(Uppsala University), Manuela Las‐Jankowska(Nicolaus Copernicus University), Katarzyna Chojnowska(Gdańsk Medical University), Łukasz Szylberg(Janelia Research Campus), Jan P. Dumanski(Uppsala University), Maciej Jaśkiewicz(Gdańsk Medical University), Jacek Hoffman, Magdalena Nowikiewicz, Jerzy Jankau(Gdańsk Medical University), Irene Tiemann‐Boege(Johannes Kepler University of Linz), Joanna Szpor(Jagiellonian University), Ewa Śrutek(Nicolaus Copernicus University), Diana Hodorowicz‐Zaniewska(Jagiellonian University), Kinga Drężek-Chyła(Gdańsk Medical University), Wojciech Zegarski(Nicolaus Copernicus University), Mikołaj Koszyński(Gdańsk Medical University), Dariusz Bała(Nicolaus Copernicus University), Marta Drzewiecka-Kłysz, Patrick G. Buckley(Gene Therapy Laboratory), Natalia Filipowicz(Gdańsk Medical University), Piotr Madanecki(Gdańsk Medical University)
BMC Cancer
April 30, 2026
Cited by 0


Related Papers